| Management of newly diagnosed glioblastoma: guidelines development, value and application. | |
| | |
MedLine Citation:
|
PMID: 19430879 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The movement to create guidelines for management of medical maladies has been gaining strength for quality, academic, financial and political purposes over the past two decades. This applies to neurological diseases, too. Evidence-based guidelines created in a multidisciplinary fashion using predetermined criteria for grading scientific data and translating this to similarly ranked recommendations is a valuable approach to meeting this goal. The following is a summary of the methods used for, and the results of, an evidence-based guideline for the management of newly diagnosed glioblastoma. In addition to outlining recommendations by discipline, it also addresses how concerns and conflicts were addressed in their development and provides comment on future directions in management of this situation that may improve outcome. It is important that clinicians directly experienced in patient management take the lead in creation of guidelines related to the diseases they deal with, as these clinicians are clearly the most suited to being able to arrive at a meaningful and useful product. |
| | |
Authors:
|
Jeffrey J Olson; Camilo E Fadul; Daniel J Brat; Srinivasan Mukundan; Timothy C Ryken |
Related Documents
:
|
19191719 - New european guidelines for cardiovascular disease prevention in clinical practice. 21087469 - Developing a computer delivered, theory based intervention for guideline implementation... 11830709 - Clinical management guidelines for osteoporosis in hong kong the working group for form... 11899139 - Guidelines for care of contact dermatitis. 10173259 - Practice guidelines in finland: availability and quality. 9484929 - Principles and guidelines for surgeons: management of cutaneous malignant melanoma. eur... 3806489 - The outcome of hidden neurotic illness treated in general practice. 22125249 - Online professional networks for physicians: risk management. 19063819 - The pharmacogenetics of asthma treatment. |
Publication Detail:
|
Type: Journal Article; Review Date: 2009-05-09 |
Journal Detail:
|
Title: Journal of neuro-oncology Volume: 93 ISSN: 1573-7373 ISO Abbreviation: J. Neurooncol. Publication Date: 2009 May |
Date Detail:
|
Created Date: 2009-05-11 Completed Date: 2009-07-15 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8309335 Medline TA: J Neurooncol Country: United States |
Other Details:
|
Languages: eng Pagination: 1-23 Citation Subset: IM |
Affiliation:
|
Department of Neurosurgery, Emory University School of Medicine, Atlanta, GA 30322, USA. jeffrey.olson@emory.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Brain Neoplasms
/
therapy* Evidence-Based Medicine / standards* Glioblastoma / therapy* Humans Practice Guidelines as Topic / standards* |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: LPS induces GROalpha chemokine production via NF-kappaB in oral fibroblasts.
Next Document: Racial, ethnic and socioeconomic disparities in the treatment of brain tumors.